Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 53, Issue 3, 2013, Pages 293-297

  Hahn, Ho Suap ^a   Lee, In Ho ^a   Kim, Tae Jin ^a   Lee, Ki Heon ^a   Shim, Jae Uk ^a   Kim, Jae Wook ^a   Lim, Kyung Taek ^a  

^a Kwandong University College of Medicine   (South Korea)

Author keywords

endometrial cancer; lymphadenectomy; lymphovascular space invasion; metastasis; recurrence

Indexed keywords

ADULT; AGED; ARTICLE; ASCITES FLUID CYTOLOGY; CANCER RECURRENCE; CANCER STAGING; DISEASE FREE SURVIVAL; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; LAPAROSCOPY; LAPAROTOMY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOVASCULAR SPACE INVASION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PREDICTIVE VALUE; PRIORITY JOURNAL; TUMOR INVASION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84878533653     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/ajo.12089     Document Type: Article

References (19)

1. Ueda SM, Kapp DS, Cheung MK, et al,. Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths. Am J Obstet Gynecol 2008; 198: 218.e1-218.e6.
2. Pecorelli S,. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009; 105: 103-104.
3. Sivridis E, Buckley CH, Fox H,. The prognostic significance of lymphatic vascular space invasion in endometrial adenocarcinoma. Br J Obstet Gynaecol 1987; 94: 991-994.
4. Tsuruchi N, Kaku T, Kamura T, et al,. The prognostic significance of lymphovascular space invasion in endometrial cancer when conventional hematoxylin and eosin staining is compared to immunohistochemical staining. Gynecol Oncol 1995; 57: 307-312.
5. Morrow CP, Bundy BN, Kurman RJ, et al,. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991; 40: 55-65.
6. Creasman WT, Morrow CP, Bundy BN, et al,. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 1987; 60: 2035-2041.
7. Cohn DE, Horowitz NS, Mutch DG, et al,. Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer? Gynecol Oncol 2002; 87: 243-246.
8. Mariani A, Webb MJ, Keeney GL, et al,. Assessment of prognostic factors in stage IIIA endometrial cancer. Gynecol Oncol 2002; 86: 38-44.
9. Mariani A, Webb MJ, Keeney GL, et al,. Predictors of lymphatic failure in endometrial cancer. Gynecol Oncol 2002; 84: 437-442.
10. O'Hanlan KA, Kargas S, Schreiber M, et al,. Ovarian carcinoma metastases to gastrointestinal tract appear to spread like colon carcinoma: implications for surgical resection. Gynecol Oncol 1995; 59: 200-206.
11. Paladini D, Cross P, Lopes A, Monaghan JM,. Prognostic significance of lymph node variables in squamous cell carcinoma of the vulva. Cancer 1994; 74: 2491-2496.
12. Talbot IC, Ritchie S, Leighton MH, et al,. Spread of rectal cancer within veins. Histologic features and clinical significance. Am J Surg 1981; 141: 15-17.
13. Katz A, Strom EA, Buchholz TA, et al,. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys 2001; 50: 735-742.
14. Kamelle SA, Rutledge TL, Tillmanns TD, et al,. Surgical-pathological predictors of disease-free survival and risk groupings for IB2 cervical cancer: do the traditional models still apply? Gynecol Oncol 2004; 94: 249-255.
15. Ambros RA, Kurman RJ,. Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus. Cancer 1992; 69: 1424-1431.
16. Keys HM, Roberts JA, Brunetto VL, et al,. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004; 92: 744-751.
17. Desrosiers L, Fadare O, Xiao ZF, et al,. Lymphovascular space invasion does not predict vaginal relapses in stage I endometrioid adenocarcinoma of the endometrium. Ann Diagn Pathol 2008; 12: 112-117.
18. Briet JM, Hollema H, Reesink N, et al,. Lymphvascular space involvement: an independent prognostic factor in endometrial cancer. Gynecol Oncol 2005; 96: 799-804.
19. Hanson MB, van Nagell JR Jr, Powell DE, et al,. The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer. Cancer 1985; 55: 1753-1757.